Blair William & Co. IL reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 6.4% in the 1st quarter, HoldingsChannel reports. The firm owned 11,306 shares of the company’s stock after selling 775 shares during the period. Blair William & Co. IL’s holdings in Henry Schein were worth $922,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BI Asset Management Fondsmaeglerselskab A S grew its holdings in Henry Schein by 31.4% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 9,657 shares of the company’s stock worth $787,000 after acquiring an additional 2,307 shares during the last quarter. C M Bidwell & Associates Ltd. acquired a new stake in shares of Henry Schein in the first quarter valued at approximately $234,000. National Pension Service acquired a new position in Henry Schein during the 1st quarter worth $2,881,000. ProShare Advisors LLC boosted its position in Henry Schein by 16.0% in the 1st quarter. ProShare Advisors LLC now owns 21,278 shares of the company’s stock valued at $1,735,000 after buying an additional 2,933 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Henry Schein by 0.8% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,133,238 shares of the company’s stock valued at $92,404,000 after buying an additional 8,728 shares during the period. 93.31% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, CEO David B. Brous, Jr. sold 11,157 shares of the firm’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $74.86, for a total transaction of $835,213.02. Following the sale, the chief executive officer now directly owns 68,690 shares in the company, valued at $5,142,133.40. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 1.14% of the company’s stock.
Analysts Set New Price Targets
Henry Schein Price Performance
HSIC opened at $74.19 on Friday. The company has a fifty day simple moving average of $78.12 and a 200 day simple moving average of $78.70. The company has a quick ratio of 0.91, a current ratio of 1.72 and a debt-to-equity ratio of 0.27. The stock has a market cap of $9.69 billion, a P/E ratio of 21.82, a P/E/G ratio of 2.08 and a beta of 0.83. Henry Schein, Inc. has a 12 month low of $64.75 and a 12 month high of $89.72.
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings results on Monday, August 7th. The company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.03. Henry Schein had a return on equity of 15.76% and a net margin of 3.64%. The company had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.13 billion. During the same period in the prior year, the company earned $1.16 earnings per share. The company’s revenue for the quarter was up 2.3% compared to the same quarter last year. On average, research analysts expect that Henry Schein, Inc. will post 5.27 EPS for the current year.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- Five stocks we like better than Henry Schein
- How to Invest in Marijuana Stocks
- These 3 Wood Stocks are about to go on Discount
- What is the Nikkei 225 index?
- Same Coin, Different Sides: 2 Observability Stocks Reverse Ways
- How to Invest in Toy Stocks
- 3 Stocks Awaiting Winter Winds of Opportunity
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.